Feb. 26 (UPI) -- A federal judge ruled Monday that former Turing Pharmaceuticals CEO Martin Shkreli cost investors more than $10.4 million in a Ponzi scheme.
U.S. District Judge Kiyo Matsumoto found that Shkreli, 34, lied to investors in a hedge fund to encourage them to put up $6.3 million and lost $4 million belonging to investors from another fund by funneling their money into a drug company he founded, called Retrophin Inc.